Albumin And Creatinine Tests Market Report 2025: Exponential Growth With Rising Prevalence Of Chronic Kidney Diseases
The Business Research Company
Albumin And Creatinine Tests Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, March 24, 2025 /EINPresswire.com/ -- Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
The albumin and creatinine tests market size has grown exponentially in recent years. It will grow from $2.95 billion in 2024 to $3.61 billion in 2025 at a compound annual growth rate CAGR of 22.6%. The growth in the historic period can be attributed to the rising prevalence of chronic kidney diseases CKD and diabetes, growing awareness of early diagnostic tools for renal health, increasing adoption of point-of-care testing devices, expanding healthcare infrastructure in emerging markets, and technological advancements in diagnostic testing methods.
Is the Market Set to Witness Substantial Growth?
The albumin and creatinine tests market is set for exponential growth in the coming years, reaching $8.05 billion by 2029 at a CAGR of 22.2%. This growth will be driven by rising demand for home-based and remote diagnostics, increased AI integration in precision testing, a stronger emphasis on preventive healthcare and early disease detection, expansion of personalized medicine, and government support for kidney health awareness programs.
What is driving these emerging trends and rapid market growth?
The rise in chronic kidney diseases CKD is propelling the growth of the albumin and creatinine tests market. CKD refers to the gradual loss of kidney function over time, where the kidneys are unable to filter waste and excess fluids from the blood effectively, resulting in a buildup of toxins and potentially causing complications in various bodily systems. An increase in risk factors such as diabetes, hypertension, and obesity is driving the rising incidence of CKD.
These albumin and creatinine tests help diagnose and monitor CKD by measuring protein levels, such as albumin, in the urine and evaluating kidney function through creatinine levels. Consequently, these tests enable early detection and management of kidney damage. For instance, in June 2023, Kidney Research UK, a UK-based non-profit organization, reported that currently, around 7.2 million people in the UK, accounting for over 10% of the population, are living with CKD. This includes 3.25 million in advanced stages and 3.9 million in early stages. By 2033, that number is expected to increase to 7.61 million.
Get Your Free Sample Market Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=21091&type=smp
Who are the key players in the albumin and creatinine tests market?
Major companies operating in this market include Siemens Healthineers Company, Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, FUJIFILM Corporation, Laboratory Corporation of America Holdings, Sysmex Corporation, Ortho Clinical Diagnostics Inc., Randox Laboratories Ltd., Nova Biomedical Corporation, Eagle Biosciences Inc., Sekisui Diagnostics LLC, BTNX Inc., RayBiotech Life Inc., ARKRAY Inc., PromoCell GmbH, Arbor Assays Inc., Teco Diagnostics Inc., J. Mitra & Co. Pvt. Ltd., and Anamol Laboratories Pvt. Ltd.
What emerging trends are these key players focusing on?
Companies are focusing on innovative technologies such as smartphone-based testing, which analyze urine samples to determine a patient's albumin-to-creatinine ratio, assisting in predicting chronic kidney disease. Smartphone-based testing utilizes mobile phone technology, including apps and external devices, to conduct diagnostic tests and analyze health data, providing quick and accessible results.
In July 2022, Healthy-io, a UK-based health technology company, received approval from the U.S. Food and Drug Administration FDA for its Minuteful Kidney Test, a smartphone-based AI-powered diagnostic tool. This easy-to-use test allows patients to perform the test at home with a smartphone and a special test strip, providing real-time results and enabling early detection of kidney disease.
Order Your Report Now For A Swift Delivery: https://www.thebusinessresearchcompany.com/report/albumin-and-creatinine-tests-global-market-report
How is the albumin and creatinine tests market segmented?
The albumin and creatinine tests market is segmented by product, type, and end-user. Product divisions include Dipsticks And Kits, Analyzers, Cartridges, Reagents, and Other Products. The types segmented are Blood And Urine Creatinine, Urine Albumin, and Glycated Albumin, while end-users encompass Hospital And Clinics, Diagnostic Laboratories, Research Laboratories And Institutes, and Other End-Users.
Where are the regional hotspots for the albumin and creatinine tests market?
North America was the largest regional player in the albumin and creatinine tests market in 2024. However, Asia-Pacific is expected to emerge as the fastest-growing region in the forecast period. Notably, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa are also significant regions covered in the albumin and creatinine tests market report.
Browse For More Similar Reports-
Stem Cell Assay Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report
Metagenomics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/metagenomics-global-market-report
Glycomics or Glycobiology Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/glycomics-or-glycobiology-global-market-report
About The Business Research Company
The Business Research Company is a trusted source for comprehensive, data-rich market research with over 15000+ reports from 27 industries covering 60+ geographies. Utilizing 1,500,000 datasets, in-depth secondary research, and insights from industry leaders, you can stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn
Distribution channels: Business & Economy, Companies, Healthcare & Pharmaceuticals Industry, International Organizations, World & Regional
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release